Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Autoantibodies against dsDNA are utilized for the diagnosis and prognosis of SLE as they are highly specific and correlate with disease activity/renal involvement. However, different detection methods are used in routine diagnostic laboratories. Farr radioimmunoassay (Farr-RIA) has been designated as the preferred method, since it provides very specific and at the same time quantitative results, enabling follow-up of level variations over time. Using intercalating fluorescent dsDNA dye would enable all the benefits of Farr-RIA without the radioactive material and organic solvents. To develop a modified fluorescent Farr method (Farr-FIA) and compare it to the classical Farr-RIA in regard to laboratory parameters, as well as clinical utility. Assays were tested on sera of 70 SLE patients, 78 other autoimmune patients, and 145 healthy blood donors. DNA for Farr-FIA was isolated from healthy donor, for Farr-RIA, 14 C-labeled dsDNA from E. coli was used and mixed with sera in borate-buffered saline, followed by precipitation with saturated ammonium sulfate solution and centrifugation. The supernatant (S) was separated from the precipitate (P), and content of dsDNA was measured with PicoGreen (Invitrogen) in Farr-FIA or radioactive isotope in scintillation solution in Farr-RIA. The results were calculated as a ratio (P-S)/(P+S). Farr-FIA has a diagnostic sensitivity of 53% and diagnostic specificity of 100% (ROC AUC 0.781). Good correlation and agreement were shown between Farr-RIA and Farr-FIA. Also, there is good correlation between Farr-FIA and SLEDAI, comparable to that of Farr-RIA. Farr-FIA differs from Farr-RIA in the changed detection system yielding comparable results and thus could represent a nonradioactive replacement for Farr-RIA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical evaluation of Farr-FIA showed promising results and good correlation with Farr-RIA (sensitivity 53.0%, specificity 100%) [46].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [46]
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Measurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus
Pincus, T., Schur, P. H., Rose, J. A., Decker, J. L., & Talal, N. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909252811304 · Cited by 441
Wold, R. T., Young, F. E., Tan, E. M., & Farr, R. S. (1968) · Science · doi:10.1126/science.161.3843.806 · Cited by 378
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
A DNA-Reacting Factor in Serum of a Patient with Lupus Erythematosus Diffusus.
Ceppellini, R., Polli, E., & Celada, F. (1957) · Experimental Biology and Medicine · doi:10.3181/00379727-96-23544 · Cited by 249
Pitfalls of DNA Quantification Using DNA-Binding Fluorescent Dyes and Suggested Solutions
Nakayama, Y., Yamaguchi, H., Einaga, N., & Esumi, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150528 · Cited by 169
Research works printed but not linked: 1
- CLSI (2014) Evaluation of precision of quantitative measurement procedures; approved guideline - third edition. CLSI document EP05-A3. Clinical and Laboratory Standards Institute,
Cited by
Laboratory evaluation of anti-dsDNA antibodies.
Cockx, M., Van Hoovels, L., De Langhe, E., Lenaerts, J., Thevissen, K., Persy, B., Bonroy, C., Vercammen, M., & Bossuyt, X. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.12.029 · Cited by 30
Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review.
Orme, M. E., Voreck, A., Aksouh, R., & Schreurs, M. W. J. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab146 · Cited by 30
“In addition there were 15 studies (41, 46, 51–53, 55–59, 63–65, 68, 69) with test accuracy data for 16 different ELISA tests, with 11 studies (41, 42, 48, 49, 51, 54, 57, 60, 62, 65, 68) covering 9 different Farr-RIA tests and 2 studies (27, 49) covering 2 different Farr-FIA tests.”
MethodThe role of bacterial DNA containing CpG motifs in diseases
Zhou, J., & Deng, G. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1220-748rrrrr · Cited by 30
Bauer, C.-J., Karakostas, P., Weber, N., Behning, C., Stoffel‐Wagner, B., Brossart, P., Dolscheid‐Pommerich, R., & Schäfer, V. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305865 · Cited by 21
Update and clinical management of anti-DNA auto-antibodies
Rodríguez, C. G., Hernández, M. B. A., & Torres, I. A. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0008 · Cited by 10
Metadata
- Authors
- Lakota, K., Švec, T., Kveder, T., Sodin-Šemrl, S., Žigon, P., Ambrožič, A., Ogrič, M., Markez, S., Božič, B., Tomšič, M., & Čučnik, S.
- Affiliations
- University of Primorska (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Corresponding author
- Lakota, K.
- Švec, T.
- Kveder, T.
- Žigon, P.
- Ambrožič, A.
- Ogrič, M.
- Markez, S.
- Božič, B.
- Tomšič, M.
- Čučnik, S.
- Venue
- Clinical Rheumatology
- Published
- 2018-09-10
- Volume
- 38
- Issue
- 2
- Pages
- 353-359
- ISSN
- 0770-3198 (ISSN-L)
- 1434-9949
- OpenAlex
- W2892213835
- Cited by
- 10
- References
- 29
- Citations by year
- 2026: 2 · 2023: 2 · 2022: 2 · 2021: 4
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, non-radioactive assay, sensitivity and specificity, SLEDAI, disease activity monitoring, renal involvement
- MeSH terms
- Adult, Antibodies, Antinuclear, Cross-Sectional Studies, Diagnostic Tests, Routine, DNA, Female, Humans, Lupus Erythematosus, Systemic, Male, Radioimmunoprecipitation Assay, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories. https://app.cochat.ai/papers/10.1007/s10067-018-4271-3
- The paper
- Lakota, K., Švec, T., Kveder, T., Sodin-Šemrl, S., Žigon, P., Ambrožič, A., Ogrič, M., Markez, S., Božič, B., Tomšič, M., & Čučnik, S. (2019). Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories. Clinical Rheumatology. https://doi.org/10.1007/s10067-018-4271-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.